Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria.
Oncology
; 101(9): 575-583, 2023.
Article
in En
| MEDLINE
| ID: mdl-37459848
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Hepatitis C
/
Carcinoma, Hepatocellular
/
Liver Neoplasms
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Oncology
Year:
2023
Type:
Article
Affiliation country:
Japan